Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

Active substance factsheet - Last updated: 04/03/2021

Active substance

Substance name:

EC number:

-

CAS number:

66603-10-9

IUPAC name:

Cyclohexylhydroxydiazene 1-oxide, potassium salt (This entry also covers the hydrated forms of K-HDO)

BAS number:

40

Product-type:

PT08

Candidate for substitution:

Under assessment

Regulatory categorisation:

Review programme substance

Approval/Assessment status:

Approved - Renewal in progress
Competent authority evaluation

Harmonised classification and labeling of the substance
Related authorised biocidal products

No related authorised products are available

Approval data details
Administrative identifiers

Evaluating competent authority:

Austria

R4BP asset number:

EU-0005384-0000

Approval identifiers
Validity of approval

Start date:

01/07/2010

End date:

31/12/2022

Documents
Assessment Reports

Assessment Report

Study summaries (Document III-A)
Other documents
Renewal of active substance
Assessment information

Evaluating competent authority:

Austria

Assessment outcome:

In progress

Conclusion date:

Validity of approval

Start date:

End date:

Legal act:

Documents
Assessment Reports
Study summaries (Document III-A)
Other documents
Amendment of active substance - Conclusion Date: 15/01/2020
Assessment information

Evaluating competent authority:

European Commission

Assessment outcome:

Successful

Conclusion date:

15/01/2020

Validity of approval

Start date:

01/07/2010

End date:

31/12/2022

Documents
Assessment Reports

Assessment Report

Study summaries (Document III-A)
Other documents
Approval of active substance - Conclusion Date: 28/07/2008
Assessment information

Evaluating competent authority:

Austria

Assessment outcome:

Successful

Conclusion date:

28/07/2008

Validity of approval

Start date:

01/07/2010

End date:

30/06/2020

Documents
Assessment Reports

Assessment Report

Study summaries (Document III-A)
Other documents